524506

Coral Labs. financials

Market cap
₹209 Cr
Sector
Healthcare

What Coral Labs. does

Coral Laboratories Limited is a pharmaceutical company that manufactures finished pharmaceutical products at two plants — one in Daman and one in Selaqui, Dehradun (Uttarakhand). The company continues to operate in a single reportable segment, pharmaceuticals, with no change in the nature of its business during FY25. Shareholders approved broadening the company's Memorandum of Association to also permit dealing in veterinary, aqua and herbal healthcare products, alongside its core human pharmaceutical formulations business.

Segments

  • Pharmaceuticals
Manufacturing plants
2 — Daman and Selaqui (Dehradun, Uttarakhand)
Reportable business segments
1 (Pharmaceuticals)
Headquarters Ghatkopar (W), Mumbai, Maharashtra Company website

Quarterly results

Q1 FY27: revenue up 57.4%, net profit up 110.5% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue32 23 28 19 19 −41%22 −6%26 −6%30 +57%
EBITDA7 6 3 2 5 −24%2 −70%6 +130%5 +152%
Net profit6 6 3 3 6 −9%3 −55%5 +84%5 +111%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +12.1% 1Y

₹400₹500₹600Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹521.8 on 10 Sept 2025 → ₹585. High ₹665.15 (19 Aug 2026), low ₹362.05 (27 Mar 2026).

Financials, as filed

Revenue grew 3.2% a year over 3 years, FY23 to FY26. Operating margin widened to 17.7%.

Year endingFY23FY24FY25FY26
Revenue₹78 Cr₹84 Cr₹115 Cr₹86 Cr
Operating profit₹4 Cr₹16 Cr₹26 Cr₹15 Cr
Operating margin4.9%19.4%22.8%17.7%
Interest₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Depreciation₹2 Cr₹2 Cr₹2 Cr₹2 Cr
Net profit₹6 Cr₹16 Cr₹24 Cr₹16 Cr
Net margin8.3%18.9%21.0%19.1%
Cash from operations₹13 Cr₹-5 Cr₹-1 Cr₹16 Cr
Free cash flow₹11 Cr₹-6 Cr₹-4 Cr₹-5 Cr
ROCE5.0%13.0%17.0%11.0%
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY21FY22FY23FY24FY25FY26
Equity capital₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
Reserves₹133 Cr₹152 Cr₹151 Cr₹174 Cr₹210 Cr₹206 Cr
Borrowings₹6 Cr₹6 Cr₹0 Cr₹0 Cr₹1 Cr₹4 Cr
Other liabilities₹25 Cr₹28 Cr₹20 Cr₹28 Cr₹19 Cr₹27 Cr
Total liabilities₹168 Cr₹190 Cr₹174 Cr₹206 Cr₹233 Cr₹241 Cr
Fixed assets₹21 Cr₹24 Cr₹25 Cr₹24 Cr₹24 Cr₹44 Cr
Capital work in progress₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹14 Cr₹0 Cr
Investments₹33 Cr₹46 Cr₹41 Cr₹50 Cr₹57 Cr₹46 Cr
Other assets₹112 Cr₹118 Cr₹108 Cr₹132 Cr₹138 Cr₹150 Cr
Total assets₹168 Cr₹190 Cr₹174 Cr₹206 Cr₹233 Cr₹241 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

The ownership split has held steady since Jun 2025. The shareholder count shrank 8% to 3,873.

Promoters
71.5%
Public
28.5%

Since Jun 2025

  • Public −0.01 pp
  • Promoters 0.00 pp
  • FIIs 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 71.5%, FIIs 0.1%, Public 28.3%.Dec '23: Promoters 71.5%, FIIs 0.1%, Public 28.4%.Mar '24: Promoters 71.5%, FIIs 0.1%, Public 28.4%.Jun '24: Promoters 71.5%, FIIs 0.2%, Public 28.3%.Sep '24: Promoters 71.5%, Public 28.5%.Dec '24: Promoters 71.5%, Public 28.5%.Mar '25: Promoters 71.5%, Public 28.5%.Jun '25: Promoters 71.5%, Public 28.5%.Sep '25: Promoters 71.5%, Public 28.5%.Dec '25: Promoters 71.5%, Public 28.5%.Mar '26: Promoters 71.5%, Public 28.5%.Jun '26: Promoters 71.5%, Public 28.5%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Coral Labs. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Chetan Navinchandra Doshi 51.54%unchanged
Coral India Finance and Housing Limited 19.97%unchanged
Investor Education And Protection Fund Authority Ministry Of Corporate Affairs 2.64%newly disclosed
Meeta Samir Sheth 1.84%unchanged
Pooja Bhagwandas 1.83%unchanged
Neelam Mittal 1.14%unchanged
Noetic Finance Private Limited 1.06%unchanged
Manav Chetan Doshi 0.00%newly disclosed
Meera Chetan Doshi 0.00%newly disclosed
Kundan Navinchandra Doshi 0.00%unchanged
Navinchandra Bachubhai Doshi 0.00%unchanged
Iepf —off the list

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

What the price assumes

Attractive

To justify its price of ₹585, this stock must grow earnings at 9% every year for 7 years. Our analysis caps realistic growth at ~36%. At that growth it is worth ₹2401 — upside of 310%.

Growth the price implies
8.6% a year
for 7 years, fading to 4%
It has actually compounded at
36.4% a year
net profit, FY23–FY26 · EPS 36.4%
The gap
-0.3 pp
310% downside if it only repeats history
Price today ₹585 Value at the reference growth ₹2,401.24

Change the assumptions yourself →

Learn to analyse Coral Labs.

Guides on how to read this kind of business and the numbers that matter.